MYNZ – mainz biomed n.v. - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MYNZ

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/13

07:43 am

mynz

Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY [Yahoo! Finance]

Neutral Report

Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY [Yahoo! Finance]

Report

3/11

07:30 am

mynz

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Medium Report

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Report

3/7

05:30 am

mynz

Mainz Biomed (MYNZ) was downgraded by Maxim Group from "strong-buy" to "hold".

Medium Report

Mainz Biomed (MYNZ) was downgraded by Maxim Group from "strong-buy" to "hold".

Report

2/24

07:47 am

mynz

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples [Yahoo! Finance]

Low Report

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples [Yahoo! Finance]

Report

2/24

07:30 am

mynz

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Medium Report

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Report

2/17

07:30 am

mynz

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

High Report

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Report

1/14

09:15 am

mynz

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

Low Report

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

Report

1/5

09:20 am

mynz

Mainz Biomed Provides Review of 2025 Highlights [Yahoo! Finance]

Medium Report

Mainz Biomed Provides Review of 2025 Highlights [Yahoo! Finance]

Report

1/5

09:15 am

mynz

Mainz Biomed Provides Review of 2025 Highlights

Medium Report

Mainz Biomed Provides Review of 2025 Highlights

Report

12/27

01:05 am

mynz

Mainz Biomed (NASDAQ:MYNZ) was upgraded by analysts at Wall Street Zen

Medium Report

Mainz Biomed (NASDAQ:MYNZ) was upgraded by analysts at Wall Street Zen

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.